Literature DB >> 23604550

Functional differences between aggregated and dispersed insulin-producing cells.

A Chowdhury1, O Dyachok, A Tengholm, S Sandler, P Bergsten.   

Abstract

AIMS/HYPOTHESIS: Beta cells situated in the islet of Langerhans respond more vigorously to glucose than do dissociated beta cells. Mechanisms for this discrepancy were studied by comparing insulin-producing MIN6 cells aggregated into pseudoislets with MIN6 monolayer cells and mouse and human islets.
METHODS: MIN6 monolayers, pseudoislets and mouse and human islets were exposed to glucose, α-ketoisocaproic acid (KIC), pyruvate, KIC plus glutamine and the phosphatidylinositol 3-kinase (PI3K) inhibitors LY294002 or wortmannin. Insulin secretion (ELISA), cytoplasmic Ca(2+) concentration ([Ca(2+)]c; microfluorometry), glucose oxidation (radiolabelling), the expression of genes involved in mitochondrial metabolism (PCR) and the phosphorylation of insulin receptor signalling proteins (western blotting) were measured.
RESULTS: Insulin secretory responses to glucose, pyruvate, KIC and glutamine were higher in pseudoislets than monolayers and comparable to those of human islets. Glucose oxidation and genes for mitochondrial metabolism were upregulated in pseudoislets compared with single cells and monolayers, respectively. Phosphorylation at the inhibitory S636/639 site of IRS-1 was significantly higher in monolayers and dispersed human and mouse cells than pseudoislets and intact human and mouse islets. PI3K inhibition only slightly attenuated glucose-stimulated insulin secretion from monolayers, but substantially reduced that from pseudoislets and human and mouse islets without suppressing the glucose-induced [Ca(2+)]c response. CONCLUSIONS/
INTERPRETATION: We propose that islet architecture is critical for proper beta cell mitochondrial metabolism and IRS-1 signalling, and that PI3K regulates insulin secretion at a step distal to the elevation of [Ca(2+)]c.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23604550      PMCID: PMC3671110          DOI: 10.1007/s00125-013-2903-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  49 in total

1.  Islet alpha-cells do not influence insulin secretion from beta-cells through cell-cell contact.

Authors:  Helen Brereton; Melanie J Carvell; Shanta J Persaud; Peter M Jones
Journal:  Endocrine       Date:  2007-02       Impact factor: 3.633

2.  Pancreatic β-cell Raf-1 is required for glucose tolerance, insulin secretion, and insulin 2 transcription.

Authors:  Emilyn U Alejandro; Gareth E Lim; Arya E Mehran; Xiaoke Hu; Farnaz Taghizadeh; Dmytro Pelipeychenko; Manuela Baccarini; James D Johnson
Journal:  FASEB J       Date:  2011-08-04       Impact factor: 5.191

3.  Pulsatile insulin release from islets isolated from three subjects with type 2 diabetes.

Authors:  Jian-Man Lin; Marta E Fabregat; Ramon Gomis; Peter Bergsten
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

4.  Insulin resistance: a phosphorylation-based uncoupling of insulin signaling.

Authors:  Y Zick
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

5.  Pancreatic beta-cell-to-beta-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets.

Authors:  A C Hauge-Evans; P E Squires; S J Persaud; P M Jones
Journal:  Diabetes       Date:  1999-07       Impact factor: 9.461

6.  Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines.

Authors:  R N Kulkarni; J N Winnay; M Daniels; J C Brüning; S N Flier; D Hanahan; C R Kahn
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

7.  Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic beta-cells. Potential role in nutrient sensing.

Authors:  N Sekine; V Cirulli; R Regazzi; L J Brown; E Gine; J Tamarit-Rodriguez; M Girotti; S Marie; M J MacDonald; C B Wollheim
Journal:  J Biol Chem       Date:  1994-02-18       Impact factor: 5.157

8.  Effects of intravenous infusion of 17 amino acids on the secretion of GH, glucagon, and insulin in sheep.

Authors:  T Kuhara; S Ikeda; A Ohneda; Y Sasaki
Journal:  Am J Physiol       Date:  1991-01

9.  Microfluidic device for multimodal characterization of pancreatic islets.

Authors:  Javeed Shaikh Mohammed; Yong Wang; Tricia A Harvat; Jose Oberholzer; David T Eddington
Journal:  Lab Chip       Date:  2008-10-21       Impact factor: 6.799

10.  Ca2+-induced Ca2+ release by activation of inositol 1,4,5-trisphosphate receptors in primary pancreatic beta-cells.

Authors:  Oleg Dyachok; Gunnar Tufveson; Erik Gylfe
Journal:  Cell Calcium       Date:  2004-07       Impact factor: 6.817

View more
  16 in total

1.  Mimicking Neuroligin-2 Functions in β-Cells by Functionalized Nanoparticles as a Novel Approach for Antidiabetic Therapy.

Authors:  Anna Munder; Liron L Israel; Shirin Kahremany; Rina Ben-Shabat-Binyamini; Charles Zhang; Michal Kolitz-Domb; Olga Viskind; Anna Levine; Hanoch Senderowitz; Steven Chessler; Jean-Paul Lellouche; Arie Gruzman
Journal:  ACS Appl Mater Interfaces       Date:  2017-01-03       Impact factor: 9.229

2.  Dimensionality and size scaling of coordinated Ca(2+) dynamics in MIN6 β-cell clusters.

Authors:  Thomas H Hraha; Abigail B Bernard; Linda M Nguyen; Kristi S Anseth; Richard K P Benninger
Journal:  Biophys J       Date:  2014-01-07       Impact factor: 4.033

Review 3.  Advances in islet encapsulation technologies.

Authors:  Tejal Desai; Lonnie D Shea
Journal:  Nat Rev Drug Discov       Date:  2016-12-23       Impact factor: 84.694

4.  An Islet-Targeted Genome-Wide Association Scan Identifies Novel Genes Implicated in Cytokine-Mediated Islet Stress in Type 2 Diabetes.

Authors:  Poonam R Sharma; Aaron J Mackey; Eden A Dejene; James W Ramadan; Carl D Langefeld; Nicholette D Palmer; Kent D Taylor; Lynne E Wagenknecht; Richard M Watanabe; Stephen S Rich; Craig S Nunemaker
Journal:  Endocrinology       Date:  2015-05-27       Impact factor: 4.736

5.  Compliant 3D microenvironment improves β-cell cluster insulin expression through mechanosensing and β-catenin signaling.

Authors:  Crystal E Nyitray; Miquella G Chavez; Tejal A Desai
Journal:  Tissue Eng Part A       Date:  2014-02-24       Impact factor: 3.845

6.  An assay for small scale screening of candidate β cell proliferative factors using intact islets.

Authors:  Rockann E Mosser; Maureen Gannon
Journal:  Biotechniques       Date:  2013-12       Impact factor: 1.993

7.  Controlled aggregation of primary human pancreatic islet cells leads to glucose-responsive pseudoislets comparable to native islets.

Authors:  Janneke Hilderink; Siebe Spijker; Françoise Carlotti; Lydia Lange; Marten Engelse; Clemens van Blitterswijk; Eelco de Koning; Marcel Karperien; Aart van Apeldoorn
Journal:  J Cell Mol Med       Date:  2015-03-17       Impact factor: 5.310

8.  Endodermal differentiation of human pluripotent stem cells to insulin-producing cells in 3D culture.

Authors:  Hiroki Takeuchi; Norio Nakatsuji; Hirofumi Suemori
Journal:  Sci Rep       Date:  2014-03-27       Impact factor: 4.379

9.  PI3 kinases p110α and PI3K-C2β negatively regulate cAMP via PDE3/8 to control insulin secretion in mouse and human islets.

Authors:  Jelena Kolic; Jocelyn E Manning Fox; Oleg G Chepurny; Aliya F Spigelman; Mourad Ferdaoussi; Frank Schwede; George G Holz; Patrick E MacDonald
Journal:  Mol Metab       Date:  2016-05-11       Impact factor: 7.422

10.  Evaluation of low doses BPA-induced perturbation of glycemia by toxicogenomics points to a primary role of pancreatic islets and to the mechanism of toxicity.

Authors:  E Carchia; I Porreca; P J Almeida; F D'Angelo; D Cuomo; M Ceccarelli; M De Felice; M Mallardo; C Ambrosino
Journal:  Cell Death Dis       Date:  2015-10-29       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.